Su1570 IMPACT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS CIRRHOSIS ON INPATIENT OUTCOMES AFTER ACUTE MYOCARDIAL INFARCTION

Tu1826 IMPACT OF GLP-1 RECEPTOR AGONIST ON CLINICAL OUTCOMES IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS: INSIGHTS FROM A LARGE-SCALE ...

Su1798 UPADACITINIB TREATMENT IS ASSOCIATED WITH IMPROVED CLINICAL AND QUALITY OF LIFE OUTCOMES IN PATIENTS WITH CROHN'S DISEASE: RESULTS FROM THE ...

Su1522 OPPOSING EFFECTS OF TM6SF2 GENOTYPE ON HEPATIC AND CARDIAC OUTCOMES BASED ON CLINICAL RISK FACTORS IN THE UK BIOBANK

Su1609 SEVERE OBESITY IS ASSOCIATED WITH WORSE OUTCOMES THAN LEAN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: A POPULATION-BASED COHORT STUDY ...

Sa1591 LIVER DECOMPENSATION AND MORTALITY OUTCOMES USING BAVENO VII CUTOFFS FOR TRANSIENT ELASTOGRAPHY AMONG PATIENTS WITH COMPENSATED ADVANCED CHRONIC ...

Su1532 ASSOCIATIONS BETWEEN EXERCISE PATTERNS AND CLINICAL OUTCOMES IN A PROSPECTIVE COHORT OF PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC ...

Su1543 VALIDATION OF THE LIVER RISK SCORE IN A NATIONALLY REPRESENTATIVE SAMPLE: A PROMISING NOVEL TOOL FOR PREDICTING FIBROSIS AND LIVER-RELATED OUTCOMES ...

Mo1503 GLOBAL PREVALENCE, CLINICAL CHARACTERISTICS, SURVEILLANCE, TREATMENT ALLOCATION, AND OUTCOMES OF ALCOHOL-ASSOCIATED HEPATOCELLULAR CARCINOMA: ...

Mo1535 THE ROLE OF ALCOHOL RELAPSE ON CLINICAL OUTCOMES AFTER TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT PLACEMENT